Schedule 1 Therapeutics
Biotechnology Research · 2 Employees
Email Address: g.pappas@s1therapeutics.com
- Overview
- Employees
Access 4 Verified Employees Profiles for Schedule 1 TherapeuticsUnlock Free Contacts Now
About
S1Tx is a preclinical stage biotechnology company developing cannabis-based medicines for FDA-approval in the treatment of pain and central nervous system disorders.
Funded in part by the Migraine Research Foundation and the National Institute on Drug Abuse, we were one of the 1st federal recipients of U.S. government small business grants for the development of a THC / cannabis medicine for FDA-approval. Our research is ongoing with partners at the University of Iowa, Leiden University in the Netherlands, and others.
Year Founded
--
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
222 Merchandise Mart Plaza
1230
Chicago, Illinois 60654, US
Keywords
--
Location
- 222 Merchandise Mart Plaza 1230 Chicago, Illinois 60654, US
Email Formats
Sign up for free credits and discover verified email addresses of Schedule 1 Therapeutics
FormatExamples
first + last
andywarhol@s1therapeutics.com
first_initial + last
awarhol@s1therapeutics.com
first + last_initial
andyw@s1therapeutics.com
first
andy@s1therapeutics.com
last
warhol@s1therapeutics.com
Frequently Asked Questions
Key Contacts
Similar Companies
Biotechnology Research
Get key business info for Schedule 1 Therapeutics and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.